Ketotifen: Nursing Drug Guide, Eye Drop Safety & NCLEX Review
Mast-cell stabilizing eye drops for seasonal allergic conjunctivitis—but the highest-stakes nursing problems are sterile technique and bottle contamination, using drops for contact-lens irritation when labeling forbids it, and masking serious eye disease when eye pain, vision changes, or redness/itching persist beyond 72 hours.
U.S. OTC labeling: for use in the eye only; not for contact lens related irritation; remove lenses before use; do not use if cloudy or discolored. Stop and seek care if eye pain, blurred vision, or itching/redness worsen or last more than 72 hours. Touching the dropper tip or sharing bottles risks serious infection.
📋 Contents
⚡ Quick facts
💡 Key takeaway
Before every instillation: verify the bottle is clear, the dropper never touched the eye or lashes, lenses are out, and symptoms fit allergic conjunctivitis—not lens irritation or infection. If pain, vision change, or redness/itch persist past 72 hours, stop masking and escalate for ophthalmic assessment.
Brand names and formulations
Ketotifen fumarate ophthalmic solution (typically 0.025% or 0.035% per product) is available OTC in many markets for temporary relief of itchy eyes due to allergies. This guide focuses on ophthalmic drops reviewed in current U.S. OTC labeling (Zaditor) and UK/EU product information (Zaditen).
- U.S. OTC: Zaditor; Alaway; generic ketotifen fumarate 0.035% solution
- UK/EU: Zaditen eye drops (ketotifen 0.25 mg/mL)
- Related ophthalmic agents: Olopatadine — different strength and labeling; not interchangeable
- Oral ketotifen tablets are a separate systemic product—do not confuse with eye drops
Indications
Per U.S. OTC ketotifen ophthalmic labeling:
- Temporary relief of itchy eyes due to exposure to ragweed, pollen, grass, animal hair, and dander
- Adults and children 3 years and older per OTC directions; children under 3: consult a doctor
Nurses use ketotifen for seasonal allergic eye symptoms overlapping allergic conjunctivitis, ocular itching, and urticaria pathways—but drops do not replace epinephrine or emergency care for anaphylaxis.
How it works
Ketotifen is an H1-receptor antagonist with mast-cell stabilizing activity. Topical instillation limits systemic exposure compared with oral antihistamines. Effects include reduced histamine-mediated itching and stabilization of mast cells in conjunctival tissue.
Because symptoms improve locally, nurses must still screen for conditions that need ophthalmology—not allergic itch alone (e.g. bacterial or viral conjunctivitis, corneal injury, glaucoma flare).
Dosing
Ophthalmic route only. Do not swallow. Match product concentration to the label.
| Population | Dose |
|---|---|
| Adults and children ≥3 years | 1 drop in affected eye(s) twice daily (every 8–12 hours); maximum twice daily |
| Children <3 years | Consult a doctor (OTC labeling) |
| Other ophthalmic products | Wait ≥5 minutes between different eye medications (OTC labeling) |
| Contact lenses | Remove before use; wait ≥10 minutes before reinserting (OTC labeling) |
On a small screen, swipe or scroll sideways to see the full table.
Renal or hepatic dose adjustment is not specified in reviewed U.S. ophthalmic OTC labeling—systemic exposure from topical use is low; follow prescriber and pharmacy guidance if oral ketotifen or systemic disease is also present.
Pharmacokinetics
- Absorption: Primarily local ocular effect; limited systemic absorption with punctal occlusion and proper technique
- Onset: Itch relief may begin within minutes to hours depending on product; full benefit may require continued BID use through allergy season
- Duration: Dosed every 8–12 hours per labeling—do not exceed twice daily
- Elimination: Systemic pathways matter mainly after ingestion or with oral ketotifen—not routine nursing monitoring for standard ophthalmic OTC use
Safety check — Before you give
- Right patient, drug, concentration, eye(s), time, and twice-daily maximum
- Solution is clear—not cloudy or discolored
- Indication is allergic itch—not contact lens irritation (label contraindication for that use)
- Contact lenses removed; plan 10-minute wait before reinsertion
- Dropper will not touch eye, lashes, fingers, or any surface
- Screen for eye pain, blurred vision, or prolonged redness >72 h
- Reconcile oral antihistamines (loratadine, cetirizine, diphenhydramine) via medication reconciliation
- Pregnancy or lactation—shared decision per product information
Contraindications
- Hypersensitivity to ketotifen or any ingredient (OTC labeling)
- Do not use to treat irritation related to contact lenses (OTC labeling)
- Do not use if solution is cloudy or discolored
Drug interactions
| Agent | Effect | Nursing action |
|---|---|---|
| Oral antihistamines | Additive allergy control; systemic sedation more likely from oral agents than eye drops | Document combined use; teach not to exceed oral product limits |
| Other ophthalmic drops | Dilution/washout if instilled too close together | Space ≥5 minutes between products; document order of instillation |
| Asthma inhalers / nasal steroids | Parallel allergy pathways—complementary but separate monitoring | Reinforce each product’s route and purpose |
On a small screen, swipe or scroll sideways to see the full table.
Reviewed ophthalmic OTC labeling does not list major systemic cytochrome interactions for topical use; focus nursing review on duplicate therapy and administration technique.
Administration
- Wash hands; remove contact lenses
- Instill one drop into affected eye(s); avoid touching dropper tip to eye or any surface
- Close eye gently 1–2 minutes; consider punctal occlusion for 1 minute to limit systemic absorption (especially lactation teaching)
- Wipe excess from skin; recap immediately
- Wait ≥10 minutes before reinserting contact lenses
- If using multiple eye products, wait ≥5 minutes between agents
Follow facility eye care protocols for inpatient instillation and documentation per unit policy.
Using drops for lens discomfort; extra doses beyond BID; contaminated bottle after dropper touched lashes; sharing bottles between family members; storing bottle without cap in humid bathroom.
Expected therapeutic response
- Reduced ocular itching within hours to days of regular BID use
- Less rubbing of eyes—decreased secondary irritation
- If no improvement after 72 hours, or worsening redness/pain/vision—therapy may be wrong or incomplete; escalate
Red flags — Stop and act
- Eye pain, change in vision, or continued redness
- Itching or redness worse or lasting >72 hours despite correct use (OTC labeling stop criteria)
- Cloudy, discolored, or particle-filled solution
- Signs of infection—purulent discharge, marked lid swelling, fever
- Systemic allergy with respiratory compromise—manage per anaphylaxis pathway, not drops alone
Adverse effects
| Adverse effect | Nursing notes |
|---|---|
| Ocular burning/stinging | Common transient after instillation |
| Conjunctival injection | Differentiate from worsening allergic redness |
| Headache, dry eyes, rhinitis | Reported in product information—assess other causes |
| Drowsiness (systemic/oral product) | Rare with ophthalmic use; more relevant if oral ketotifen co-prescribed |
On a small screen, swipe or scroll sideways to see the full table.
Overdose, toxicity, and antidote
Ingestion: U.S. OTC labeling advises contacting local poison control / toxicology services per facility protocol if swallowed. No specific antidote is listed for ophthalmic overdose in OTC labeling; treatment is supportive.
Excessive topical dosing: Reinforce maximum twice daily; monitor for ocular irritation. Oral ketotifen tablets are a different product with greater systemic CNS and GI effects.
Contact local poison control or medical toxicology for intentional ingestion, marked sedation, or altered mental status per facility protocol and local emergency guidance.
Look-alike / sound-alike and error prevention
- Ketotifen ophthalmic vs oral ketotifen — different indications and toxicity profile
- Zaditor vs Zaditen — verify concentration (0.025% vs 0.035% / 0.25 mg/mL) and regional labeling
- Ketotifen vs olopatadine — both allergy drops; different strengths and intervals
- Allergy eye drops vs contact lens rewetting drops — patient may confuse bottles
Practical bedside notes
| Topic | Bedside guidance |
|---|---|
| Single-patient bottle | Label with name and date opened per policy; never share |
| Lens wearers | Teach removal before drops—not treatment for lens irritation |
| 72-hour rule | No improvement—stop self-treating and seek eye assessment |
| Storage | Recap tightly; avoid bathroom steam; discard per label after opening |
On a small screen, swipe or scroll sideways to see the full table.
High-risk populations
| Population | Considerations |
|---|---|
| Contact lens wearers | Higher risk of using drops for wrong indication; teach lens removal and 10-minute wait |
| Children <3 years | OTC: consult doctor; ingestion risk if bottle accessible |
| Pregnancy | No adequate human data; caution—systemic levels lower with eye drops per SPC-style information |
| Lactation | Topical use unlikely to produce detectable milk levels; can use per SPC/LactMed-style guidance; teach punctal occlusion |
| Contact lens-related red eye | May signal infection or corneal injury—do not mask with allergy drops |
On a small screen, swipe or scroll sideways to see the full table.
Monitoring and documentation
Monitor
- Itch and redness trend (expect improvement within 72 h)
- New pain, blurred vision, photophobia, or discharge
- Adherence to BID schedule—not PRN extra drops
- Bottle integrity (clear solution, capped, dated)
Document
- Eye(s) treated, concentration, time, and patient tolerance
- Lens removal and post-drop wait teaching
- Prescriber/ophthalmology referral if 72-hour criteria met
Patient teaching
- For the eye only—never swallow; keep out of children’s reach
- Remove contact lenses before use; wait 10 minutes before putting lenses back in
- Do not use for contact lens irritation—see eye care professional for lens problems
- Do not touch dropper tip to eye, fingers, or any surface
- Maximum two doses per day (every 8–12 hours)
- Stop and seek care if pain, vision changes, or redness/itch last more than 72 hours
- Discard if solution looks cloudy or discolored
- If other eye drops are used, wait at least 5 minutes between products
The Hold Rule
Do not instill and contact prescriber/pharmacist/ophthalmology when:
- Known hypersensitivity to ketotifen or formulation ingredients
- Cloudy, discolored, or contaminated solution or dropper
- Patient using drops for contact lens irritation (unlabeled use)
- Eye pain, vision change, or redness/itch >72 hours without improvement
- Extra doses beyond twice daily without prescriber order
- Suspected infectious or corneal emergency—escalate before continuing allergy drops
Hold parameters may vary by institutional protocol. Follow prescriber orders, pharmacy guidance, and facility policy.
Clinical practice integration and workflow
Ketotifen is widely available OTC, so the highest-stakes problems are contaminated bottles, lens-related misuse, and delaying referral when serious eye disease presents as “allergies.”
1. Check-before-you-give protocol
- Clear solution, capped bottle, correct patient label
- Allergic itch—not lens irritation or infectious red flags
- Lenses out; spacing rules for other eye meds
- 72-hour symptom clock documented
2. High-alert and safety badge
Not a traditional high-alert medication—treat contamination, lens misuse, and masked serious eye disease as the primary safety story3. Clinical workflow: hold and question rules
- If redness worsens on day 4 despite BID use—hold and arrange ophthalmic review
- If patient reports using drops while lenses are in—stop and re-teach; assess cornea if pain present
- If bottle touched the eye—discard per policy and open new supply
4. Critical teach-back questions
- “Why must you remove contact lenses first?” (Labeling; drops are not for lens irritation.)
- “When should you stop and call for eye care?” (Pain, vision change, or symptoms >72 hours.)
5. Care coordination
Pharmacist: Product selection, spacing with other drops, oral antihistamine duplication
Ophthalmology / prescriber: Notify for pain, vision change, lack of response at 72 hours, or suspected infection
🧠 Quick mental checklist
- Is the bottle clear and the dropper untouched?
- Are lenses out—and is this allergic itch, not lens irritation?
- Has the patient already had two doses today?
- Any pain, vision change, or symptoms past 72 hours?
- Are other eye drops spaced at least 5 minutes apart?
Ketotifen NCLEX practice questions
Rehearse NCLEX-style clinical judgment practice for ketotifen ophthalmic using a tabbed case (MAR, labs, history, nursing notes), then priority action, cue recognition, trend interpretation, matrix urgency sorting, clinical judgment, and documentation cloze—recognise cues → analyse → prioritise → act → evaluate outcomes (sterile technique, contact lens safety, and when allergy drops mask serious eye disease).
Select a tab to view MAR, labs, history, and nursing note details for this case.
- Ketotifen 0.035% ophthalmic — 1 drop both eyes BID (0800, 2000)
- Loratadine 10 mg PO daily — 0800 given
- PRN artificial tears — not used today
- No acute labs ordered — outpatient allergy follow-up
- Last BMP 3 months ago: creatinine 0.9 mg/dL (stable)
- 22-year-old with seasonal allergic conjunctivitis; daily soft contact lens wearer
- Started OTC ketotifen 4 days ago for lens discomfort and itch
- No prior eye surgery; no diabetes
- Day 4: Increased redness bilaterally; patient used 3 extra drops overnight for itch
- Bottle cap left off nightstand; tip may have touched lash line
- 0900: Reports mild photophobia; vision “a little blurry” since waking
- Teach-back: patient still wearing lenses during instillation yesterday
Answer key & rationale
Frequently asked questions
Can ketotifen eye drops be used for contact lens irritation?
No. U.S. OTC labeling states the product is not for contact lens related irritation. Remove lenses before use and wait at least 10 minutes before reinserting.
When should a nurse hold ketotifen?
Hold for hypersensitivity, cloudy or discolored solution, unlabeled lens-irritation use, eye pain or vision change, symptoms beyond 72 hours without improvement, or contaminated bottle/extra doses.
How should ketotifen be spaced with other eye drops?
Wait at least 5 minutes between different ophthalmic products per U.S. OTC labeling.
Is ketotifen safe in pregnancy and breastfeeding?
Human pregnancy data are limited—use caution. Topical ophthalmic use has lower systemic exposure than oral ketotifen. Breastfeeding is generally acceptable with topical use when benefits outweigh risks; teach punctal occlusion.
What if a child swallows ketotifen eye drops?
Contact local poison control per facility protocol. Ophthalmic labeling lists no specific antidote; care is supportive. Oral ketotifen is a different product.
References
-
U.S. National Library of Medicine. Ketotifen fumarate ophthalmic solution — OTC drug facts (Zaditor). DailyMed.https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7a00b07f-3bc6-47be-8063-b2b076c69191
-
Electronic Medicines Compendium (MHRA). Zaditen (ketotifen) 0.25 mg/mL eye drops — Summary of Product Characteristics.https://www.medicines.org.uk/emc/product/1237/smpc
-
Drugs.com. Ketotifen use while breastfeeding.https://www.drugs.com/breastfeeding/ketotifen.html
-
National Institute for Health and Care Excellence. Ketotifen. British National Formulary (BNF).https://bnf.nice.org.uk/drugs/ketotifen/
Review and transparency
This medication guide is written and reviewed using NurseOnShift editorial and clinical review standards.
Educational use only. This content does not replace clinical judgment, prescriber orders, pharmacist guidance, product labeling, or institutional protocols.